Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors
Anais Brasileiros de Dermatologia · 2023
DOI: 10.1016/j.abd.2022.05.008 ↗Kurz gefasst
Fallbericht in der Zeitschrift Anais Brasileiros de Dermatologia, 2023. Verfasst von Esra Sarac und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Koc University School of Medicine, Istanbul, Turkey. Electronic address: sarac.esra@gmail.com. Hauptthemen laut MEDLINE: Skin Diseases, Neoplasms, Lymphoproliferative Disorders, Lymphoma, T-Cell, Cutaneous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
rimary cutaneous CD4+ small/medium T-cell lymphoprolifrative disorder (PCSM-TCLPD) is defined to be 6% of primary utaneous lymphomas.1 Although it is considered to have n uncertain malignant potential, it has almost always a enign prognosis with locally limited indolent tumors. Due o the benign biological behavior, World Health Organizaion’s working group renamed and classified this entity as a ymphoproliferative disorder in 2016, and it was suggested Stainings with PD-1 (Fig. 3E) and bcl-6 (Fig. 3F) were detected. CD8+ cells represent a reactive minor population. Reactive infiltrate of CD20+ B-cells was also present. Proliferative activity with Ki-67 was detected as approximately 10%--15% in the infiltration (Fig. 3G). Based on these histopathological and immunological findings, the tumor was diagnosed as PCSM-TCLPD. Due to the localization and multiplicity of the lesions, and also considering the aesthetic concern, a non-aggressive treatment option was preferred in this case. Oral doxycycline 100 mg per day was administered to our patient. Regression of the lesions started in the third week of the treatment and a total clinical remission was achieved after 4 months. She has been in our follow-up for 6 months after cessation of doxycycline and no recurrence has been observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Koc University School of Medicine, Istanbul, Turkey. Electronic address: sarac.esra@gmail.com.
- Department of Pathology, Acibadem Mehmet Ali Aydinlar University School of Medicine, Istanbul, Turkey.
Zitieren
APA
Sarac, E., & Demirkesen, C. (2023). Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2022.05.008
Vancouver
Sarac E, Demirkesen C. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors. Anais Brasileiros de Dermatologia. 2023. doi:10.1016/j.abd.2022.05.008
BibTeX
@article{Sarac2023,
author = {Sarac, Esra and Demirkesen, Cuyan},
title = {Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors},
journal = {Anais Brasileiros de Dermatologia},
year = {2023},
doi = {10.1016/j.abd.2022.05.008}
}
EUVIMED